CD19 CAR T Cells Persist Beyond a Decade

Company: University of Pennsylvania · Event Type: Technology and Modalities · Product/Asset: CD19 CAR T · Subject: CAR T-Cell Therapy · Event Date: August 10, 2026 Summary A peer-reviewed Nature Medicine study from the University of Pennsylvania characterized 4-1BB-costimulated CD19 CAR T cells up to…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *